China approves 17 anti-cancer drugs for medical insurance coverage
SHANGHAI: China has approved 17 anti-cancer drugs for inclusion in its national health insurance system, the government said on Wednesday, part of its efforts to make cancer treatment more affordable…
Affimed puts on hold cancer drug trial after patient death
Drug developer Affimed N.V. on Monday put on hold the testing of its experimental cancer drug following the death of a patient and two life-threatening events. The company’s shares slumped…
Akcea Therapeutics genetic disease treatment gets FDA approval
Akcea Therapeutics Inc said on Friday its treatment, developed along with Ionis Pharmaceuticals , which targets a rare genetic disease was approved by the U.S. Food and Drug Administration. Akcea’s…
Govt relaxes import norms for certain chemicals used in pharma sector
New Delhi: The government Wednesday relaxed import norms for about 34 chemicals used in pharmaceuticals industry, a move which would ease inbound shipments of these items. The import policy of…
More than 500 lawsuits against acne drug maker are dismissed
TRENTON, N.J.: The maker of an acne drug that caused some patients to develop a gastrointestinal disease provided adequate warnings about the drug’s side effects, New Jersey’s Supreme Court ruled…
US regulators OK updated version of decades-old antibiotic
TRENTON, N.J.: U.S. regulators on Tuesday approved a modernized version of a decades-old antibiotic used to treat a number of infections. Paratek Pharmaceuticals’ Nuzyra was designed to overcome the problem…
Sun Pharma looks to grow complex generics, specialty products biz faster
New Delhi: Drug major Sun Pharma Thursday said it is looking to raise the share of complex generics and specialty products to its overall business portfolio going forward. “While our…
GW Pharma cannabis drug set to hit market following DEA nod
U.S.: listed shares of GW Pharmaceuticals rose 8 percent on Thursday as its marijuana-based treatment Epidiolex cleared the last hurdle after the Drug Enforcement Administration labeled the drug as having…
UK biotech raises bumper $2 billion, despite Brexit blues
LONDON: Britain’s biotechnology industry has raised a bumper 1.56 billion pounds ($2.05 billion) in the first eight months of this year, surpassing the 1.2 billion reached in the whole of…
U.S. judge dismisses Teva lawsuits against Lilly on migraine drug
BOSTON: A federal judge on Thursday dismissed a pair of patent infringement lawsuits by Teva Pharmaceutical Industries Ltd that sought to block Eli Lilly and Co from bringing its migraine…
